Intravenous sphingosylphosphorylcholine protects ischemic and postischemic myocardial tissue in a mouse model of myocardial ischemia/reperfusion injury

Mediators of Inflammation

Volumn 2010, Issue , 2010, Pages

  Theilmeier, Gregor ^a   Herzog, Christine ^a   Schmitz, Martina ^b   Levkau, Bodo ^c   Herrgott, Ilka ^b   Mersmann, Jan ^b   Larmann, Jan ^a   Johanning, Kai ^a   Winterhalter, Michael ^a   Chun, Jerold ^d   Müller, Frank Ulrich ^e   Echtermeyer, Frank ^a   Hildebrand, Reinhard ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; SPHINGOSINE 1 PHOSPHATE 3 RECEPTOR; SPHINGOSINE 1 PHOSPHATE RECEPTOR; SPHINGOSYLPHOSPHORYLCHOLINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARDIOTONIC AGENT; DRUG DERIVATIVE; LYSOPHOSPHOLIPID; PHOSPHORYLCHOLINE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE 1-PHOSPHATE; SPHINGOSINE PHOSPHORYLCHOLINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIUM CELL; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE ADHERENCE; MOUSE; NEUTROPHIL; NEWBORN; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; ANIMAL; C57BL MOUSE; DRUG EFFECT; HEART; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

MUS; RATTUS;

ANIMALS; CARDIOTONIC AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART; HUMANS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MICE; MICE, INBRED C57BL; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLCHOLINE; RATS; SPHINGOSINE;

EID: 79952302719     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2010/425191     Document Type: Article

References (30)

1. Linsel-Nitschke P., Tall A. R., HDL as a target in the treatment of atherosclerotic cardiovascular disease Nature Reviews Drug Discovery 2005 4 3 193 205 (Pubitemid 40372554)
2. Nofer J. R., van der Giet M., Tlle M., Wolinska I., Von Wnuck Lipinski K., Baba H. A., Tietge U. J., Gdecke A., Ishii I., Kleuser B., Schfers M., Fobker M., Zidek W., Assmann G., Chun J., Levkau B., HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P 3 Journal of Clinical Investigation 2004 113 4 569 581 (Pubitemid 38542506)
3. Cockerill G. W., Mcdonald M. C., Mota-Filipe H., Cuzzocrea S., Miller N. E., Thiemermann C., High density lipoproteins reduce organ injury and organ dysfunction in a rat model of hemorrhagic shock FASEB Journal 2001 15 11 1941 1952 (Pubitemid 32848798)
4. Awad A. S., Ye H., Huang L., Li L., Foss F. W., Macdonald T. L., Lynch K. R., Okusa M. D., Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney American Journal of Physiology 2006 290 6 F1516 F1524
5. Kajstura J., Cheng W., Reiss K., Clark W. A., Sonnenblick E. H., Krajewski S., Reed J. C., Olivetti G., Anversa P., Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats Laboratory Investigation 1996 74 1 86 107 (Pubitemid 26041012)
6. Nakamura M., Wang N. P., Zhao Z. Q., Wilcox J. N., Thourani V., Guyton R. A., Vinten-Johansen J., Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart Cardiovascular Research 2000 45 3 661 670 (Pubitemid 30047132)
7. Theilmeier G., Schmidt C., Herrmann J., Keul P., Schrs M., Herrgott I., Mersmann J., Larmann J., Hermann S., Stypmann J., Schober O., Hildebrand R., Schulz R., Heusch G., Haude M., Lipinski K. V.W., Herzog C., Schmitz M., Erbel R., Chun J., Levkau B., High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor Circulation 2006 114 13 1403 1409 (Pubitemid 44454560)
8. Kimura T., Tomura H., Mogi C., Kuwabara A., Damirin A., Ishizuka T., Sekiguchi A., Ishiwara M., Im D. S., Sato K., Murakami M., Okajima F., Role of scavenger receptor class B type I and sphingosine 1-phosphate receptors in high density lipoprotein-induced inhibition of adhesion molecule expression in endothelial cells Journal of Biological Chemistry 2006 281 49 37457 37467 (Pubitemid 46042049)
9. Nofer J. R., Geigenmller S., Gpfert C., Assmann G., Buddecke E., Schmidt A., High density lipoprotein-associated lysosphingolipids reduce E-selectin expression in human endothelial cells Biochemical and Biophysical Research Communications 2003 310 1 98 103 (Pubitemid 37162768)
10. Levkau B., Hermann S., Theilmeier G., van der Giet M., Chun J., Schober O., Schfers M., High-density lipoprotein stimulates myocardial perfusion in vivo Circulation 2004 110 21 3355 3359 (Pubitemid 39557499)
11. Michel M. C., Mulders A. C., Jongsma M., Alewijnse A. E., Peters S. L., Vascular effects of sphingolipids Acta Paediatrica, International Journal of Paediatrics 2007 96 455 44 48 (Pubitemid 46481118)
12. Ishii I., Friedman B., Ye X., Kawamura S., McGiffert C., Contos J. J. A., Kingsbury M. A., Zhang G., Brown J. H., Chun J., Selective loss of sphingosine 1-phosphate signaling with no obvious phenotypic abnormality in mice lacking its G protein-coupled receptor, LPB3 /EDG-3 Journal of Biological Chemistry 2001 276 36 33697 33704
13. Lowell C. A., Berton G., Resistance to endotoxic shock and reduced neutrophil migration in mice deficient for the Src-family kinases Hck and Fgr Proceedings of the National Academy of Sciences of the United States of America 1998 95 13 7580 7584 (Pubitemid 28293295)
14. Nofer J. R., Assmann G., Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids Trends in Cardiovascular Medicine 2005 15 7 265 271 (Pubitemid 41437910)
15. Meyer zu Heringdorf D., Himmel H. M., Jakobs K. H., Sphingosylphosphorylcholinebiological functions and mechanisms of action Biochimica et Biophysica Acta 2002 1582 13 178 189
16. Bolick D. T., Srinivasan S., Kim K. W., Hatley M. E., Clemens J. J., Whetzel A., Ferger N., Macdonald T. L., Davis M. D., Tsao P. S., Lynch K. R., Hedrick C. C., Sphingosine-1-phosphate prevents tumor necrosis factor- -mediated monocyte adhesion to aortic endothelium in mice Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 5 976 981 (Pubitemid 40627842)
17. Hayashi T., Sumi D., Juliet P. A. R., Matsui-Hirai H., Asai-Tanaka Y., Kano H., Fukatsu A., Tsunekawa T., Miyazaki A., Iguchi A., Ignarro L. J., Gene transfer of endothelial NO synthase, but not eNOS plus inducible NOS, regressed atherosclerosis in rabbits Cardiovascular Research 2004 61 2 339 351 (Pubitemid 38091774)
18. Kuhlencordt P. J., Rosel E., Gerszten R. E., Morales-Ruiz M., Dombkowski D., Aikinson W. J., Han F., Preffer F., Rosenzweig A., Sessa W. C., Gimbrone M. A., Ertl G., Huang P. L., Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells American Journal of Physiology 2004 286 5 C1195 C1202
19. Calabresi L., Rossoni G., Gomaraschi M., Sisto F., Berti F., Franceschini G., High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor- content and enhancing prostaglandin release Circulation Research 2003 92 3 330 337 (Pubitemid 36258556)
20. Theilmeier G., De Geest B., van Veldhoven P. P., Stengel D., Michiels C., Lox M., Landeloos M., Chapman M. J., Ninio E., Collen D., Himpens B., Holvoet P., HDL-associated PAF-AH reduces endothelial adhesiveness in apoE-/- mice FASEB Journal 2000 14 13 2032 2039
21. Cockerill G. W., Huehns T. Y., Weerasinghe A., Stocker C., Lerch P. G., Miller N. E., Haskard D. O., Elevation of plasma high-density lipoprotein concentration reduces interleukin-1-induced expression of E-selectin in an in vivo model of acute inflammation Circulation 2001 103 1 108 112 (Pubitemid 32050444)
22. Blankesteijn W. M., Creemers E., Lutgens E., Cleutjens J. P. M., Daemen M. J. A. P., Smits J. F. M., Dynamics of cardiac wound healing following myocardial infarction: observations in genetically altered mice Acta Physiologica Scandinavica 2001 173 1 75 82 (Pubitemid 32948336)
23. Ovize M., Baxter G. F., Di Lisa F., Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology Cardiovascular Research 2010 87 3 406 423
24. Alewijnse A. E., Peters S. L. M., Michel M. C., Cardiovascular effects of sphingosine-1-phosphate and other sphingomyelin metabolites British Journal of Pharmacology 2004 143 6 666 684 (Pubitemid 39611603)
25. Kwon Y. B., Lee Y. S., Sohn K. C., Piao Y. J., Back S. J., Seo Y. J., Suhr KI. B., Park J. K., Kim C. D., Lee J. H., Sphingosylphosphorylcholine- induced interleukin-6 production is mediated by protein kinase C and p42/44 extracellular signal-regulated kinase in human dermal fibroblasts Journal of Dermatological Science 2007 46 2 91 99 (Pubitemid 46470073)
26. Liliom K., Sun G., Bnemann M., Virg T., Nusser N., Baker D. L., Wang D. A., Fabian M. J., Brandts B., Bender K., Eickel A., Malik K. U., Miller D. D., Desiderio D. M., Tigyi G., Pott L., Sphingosylphosphocholine is a naturally occurring lipid mediator in blood plasma: a possible role in regulating cardiac function via sphingolipid receptors Biochemical Journal 2001 355 1 189 197 (Pubitemid 32304249)
27. Nixon G. F., Mathieson F. A., Hunter I., The multi-functional role of sphingosylphosphorylcholine Progress in Lipid Research 2008 47 1 62 75 (Pubitemid 350216623)
28. Mathieson F. A., Nixon G. F., Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation British Journal of Pharmacology 2006 147 4 351 359 (Pubitemid 43292278)
29. Saini H. S., Coelho R. P., Goparaju S. K., Jolly P. S., Maceyka M., Spiegel S., Sato-Bigbee C., Novel role of sphingosine kinase 1 as a mediator of neurotrophin-3 action in oligodendrocyte progenitors Journal of Neurochemistry 2005 95 5 1298 1310 (Pubitemid 41779255)
30. Jin Z. Q., Karliner J. S., Low dose N, N-dimethylsphingosine is cardioprotective and activates cytosolic sphingosine kinase by a PKC dependent mechanism Cardiovascular Research 2006 71 4 725 734 (Pubitemid 44848008)